Vontobel Holding Ltd. Acquires 20,500 Shares of Heartflow, Inc. $HTFL

Vontobel Holding Ltd. bought a new position in shares of Heartflow, Inc. (NASDAQ:HTFL) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 20,500 shares of the company’s stock, valued at approximately $1,020,000.

Other large investors also recently bought and sold shares of the company. Avior Wealth Management LLC increased its position in shares of Heartflow by 16.1% in the third quarter. Avior Wealth Management LLC now owns 14,553 shares of the company’s stock valued at $724,000 after buying an additional 2,023 shares in the last quarter. Capital Advisors Wealth Management LLC purchased a new stake in shares of Heartflow in the 3rd quarter worth about $224,000. GAMMA Investing LLC boosted its position in shares of Heartflow by 75.1% in the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock worth $32,000 after buying an additional 275 shares in the last quarter. Valeo Financial Advisors LLC acquired a new stake in Heartflow in the 3rd quarter valued at about $213,000. Finally, Engineers Gate Manager LP acquired a new stake in Heartflow in the 2nd quarter valued at about $590,000.

Heartflow Price Performance

NASDAQ:HTFL opened at $51.02 on Tuesday. The firm has a 50 day simple moving average of $47.70 and a 200-day simple moving average of $35.53. The firm has a market cap of $4.44 billion, a PE ratio of -27.88 and a beta of 2.73. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $54.32.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million for the quarter. Heartflow’s revenue for the quarter was up 47.7% compared to the same quarter last year. As a group, sell-side analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Insider Buying and Selling at Heartflow

In other Heartflow news, insider Campbell Rogers sold 19,682 shares of the stock in a transaction on Friday, September 18th. The stock was sold at an average price of $50.15, for a total transaction of $987,052.30. Following the transaction, the insider owned 79,956 shares of the company’s stock, valued at $4,009,793.40. This represents a 19.75% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Vikram Verghese sold 29,714 shares of the firm’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $50.06, for a total value of $1,487,482.84. Following the sale, the chief financial officer owned 184,789 shares in the company, valued at $9,250,537.34. This trade represents a 13.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 304,105 shares of company stock worth $14,173,800. Insiders own 7.70% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Canaccord Genuity Group raised their target price on shares of Heartflow from $45.00 to $56.00 and gave the company a “buy” rating in a report on Tuesday, September 22nd. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Robert W. Baird set a $45.00 price target on shares of Heartflow in a research report on Friday, August 14th. JPMorgan Chase & Co. raised their price objective on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Finally, Benchmark restated a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Heartflow currently has an average rating of “Moderate Buy” and an average target price of $46.25.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence-based tools to help physicians diagnose and manage coronary artery disease. Its platform uses data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries and provide noninvasive assessments of blood flow and disease.

The company’s products include Heartflow Analysis, which provides fractional flow reserve computed tomography (FFR-CT) evaluations to help identify potentially significant blockages, as well as tools for assessing coronary plaque and planning treatment.